Cargando…
Characterization of a Novel Caveolin Modulator That Reduces Vascular Permeability and Ocular Inflammation
PURPOSE: Caveolin (Cav) regulates various aspect of endothelial cell signaling and cell-permeable peptides (CPPs) fused to domains of Cav can reduce retinal damage and inflammation in vivo. Thus, the goal of the present study was to identify a novel CPP that improves delivery of a truncated Cav modu...
Autores principales: | Bernatchez, Pascal N., Tao, Bo, Bradshaw, Ralph A., Eveleth, David, Sessa, William C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Association for Research in Vision and Ophthalmology
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8132009/ https://www.ncbi.nlm.nih.gov/pubmed/34111267 http://dx.doi.org/10.1167/tvst.10.6.21 |
Ejemplares similares
-
Caveolin-1 says NO to permeability
por: Leslie, Mitch
Publicado: (2011) -
Reexpression of caveolin-1 in endothelium rescues the vascular, cardiac, and pulmonary defects in global caveolin-1 knockout mice
por: Murata, Takahisa, et al.
Publicado: (2007) -
Cav-1 (Caveolin-1) Deficiency Increases Autophagy in the Endothelium and Attenuates Vascular Inflammation and Atherosclerosis
por: Zhang, Xinbo, et al.
Publicado: (2020) -
Caveolin as a potential drug target for cardiovascular protection
por: Sellers, Stephanie L., et al.
Publicado: (2012) -
Proliferation of Human Corneal Endothelia in Organ Culture Stimulated by Wounding and the Engineered Human Fibroblast Growth Factor 1 Derivative TTHX1114
por: Eveleth, David, et al.
Publicado: (2020)